Dianthus Therapeutics (DNTH) PT Raised to $132 at Jefferies

June 10, 2026 3:52 PM

Jefferies analyst Maury Raycroft raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $132.00 (from $110.00) while maintaining a Buy rating.

No results found